The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many

Pittsburgh Veterans Affairs (VA) Medical Center, Pittsburgh, Pennsylvania, USA.
Health Affairs (Impact Factor: 4.97). 02/2012; 31(2):408-16. DOI: 10.1377/hlthaff.2011.0469
Source: PubMed


Prescription drug spending and pharmacy benefit design have changed greatly over the past decade. However, little is known about the financial impact these changes have had on consumers. We examined ten years of nationally representative data from the Medical Expenditure Panel Survey and describe trends in two measures of financial burden for prescription drugs: out-of-pocket drug costs as a function of family income and the proportion of all out-of-pocket health care expenses accounted for by drugs. We found that although the percentage of people with high financial burden for prescription drugs increased from 1999 to 2003, it decreased from 2003 to 2007, with a slight increase in 2008. The decline is evidence of the success of strategies to lower drug costs for consumers, including the increased use of generic drugs. However, the financial burden is still high among some groups, notably those with public insurance and those with low incomes. For example, one in four nonelderly people devote more than half of their total out-of-pocket health care spending to prescription drugs. These trends suggest that the affordability of prescription drugs under the future insurance exchanges will need to be monitored, as will efforts by states to increase prescription drug copayments under Medicaid or otherwise restrict drug use to reduce public spending.

1 Follower
13 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this presentation, the requirements for analytical modeling and software development to support the emerging energy market place were discussed in detail. Emphasis was placed on the optimization technologies required to meet the current market design as it has emerged in various restructured energy systems. Further, the presentation focused on the need to deploy full network models (FNMs), enforce all network constraints and calculate LMPs at each network bus. The expectation is that the resulting optimal dispatch is accurate and realistic at the resource level. A contract was clearly drawn between the traditional requirements for EMS applications and requirements for the emerging energy market designs.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent changes in diabetes treatment guidelines and the introduction of new, more expensive pharmaceuticals appear to increase the financial challenges for nonelderly adults with diabetes. The authors used Medical Expenditure Panel Survey data to examine changes in the prevalence of diabetes and comorbidities, diabetes treatment, financial burdens, and the relationship between high financial burdens and patient characteristics. From 1997-1998 to 2006-2007, the total number of nonelderly adults treated for diabetes nearly doubled, from 5.4 to 10.7 million, and the proportion of diabetes patients using multiple drugs to treat their condition increased significantly. About a fifth of diabetes patients spent 10% or more of their family income on health care, and about one in nine spent 20% or more of their family income on health care. In 2006-2007, diabetes patients who were older, female, in poor health, or lacked insurance were more likely than others to have high burdens.
    Medical Care Research and Review 04/2012; 69(4):474-91. DOI:10.1177/1077558712442570 · 2.62 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: High medical cost burden is defined as spending more than 10 percent of family income on health care. Despite decreased family income and rising unemployment caused by the recession of 2007-09, the percentage of people under age sixty-five with high medical cost burdens remained largely unchanged between 2006 and 2009, at approximately 19 percent. That unexpected result, based on data from the Medical Expenditure Panel Surveys, contrasts with an increase from 14.4 percent to 19.2 percent in the share of people with high medical cost burdens between 2001 and 2006. The percentage did not change during the recent recession because decreased family income was offset by decreased out-of-pocket health spending. Virtually all of this decreased spending was because of lower spending on prescription drugs as people shifted from brand-name medications to less expensive generics.
    Health Affairs 10/2012; 31(11). DOI:10.1377/hlthaff.2012.0148 · 4.97 Impact Factor
Show more


13 Reads
Available from